MURRIETA, CA--(Marketwire - August 08, 2008) - CLX Medical, Inc. (OTCBB: CLXN), which is focused on the launch and distribution of unique medical diagnostic testing products, today announced that the company has reached agreement with LETI Laboratories, a Barcelona-based biopharmaceutical company, to serve as the sole importer of CLX's subsidiary products into the European market.
